Meet the Team

Emma Cartmell
Managing Partner

Emma is a healthcare industry operator, successful investor and sought after Board Member. Most recently, Emma was Managing Partner at Cartmell Ventures where she made 14 digital health investments. Additionally, Emma is an advisor to Morgan Stanley's Expansion Capital Fund and United Health Groups accelerator program. Previously, she served on the board of HIMSS North America and advised the British Government on digital health. Emma was also the founding COO for NantHealth where she oversaw over 30 digital health investments, worked as COO for Abraxis BioScience which was sold to Celgene for over $3B dollars, and served as SAIC's Vice President of business development for the Health Solutions Business Unit and VP of Healthcare Advance Programs.

With over two decades of proven leadership and investment success, Emma values leveraging technology to fix broken workflows in healthcare delivery to create an effortless patient experience, improve health outcomes and lower costs for all.

Amit Aysola
Managing Partner

Amit is a unique digital health investor with a broad range of career experiences, including as a healthcare operator, strategy consultant, and transaction advisor. His multi-disciplinary background in engineering, software management, strategic consulting, financial management, and transaction advisory centers on the next generation of transformative digital health technologies.

Amit most recently managed a healthcare portfolio for Wanxiang America, where he effectively implemented his investment thesis and value-adding approach to generate strong returns. He’s made 31 investments in five years with several successful exits. Amit provided M&A and capital raise advisory services at Healthcare Growth Partners, a leading digital health investment bank that advised on the largest number of healthcare M&A deals in the U.S. He previously managed product testing, product deployments, and customer success at Plan Data Management, a digital health startup eventually sold to Trizetto Corporation, which provided a unique perspective on how best to design software products in such a way as to maximize customer acceptance.

Amit was listed in Global Corporate Venturing's Top 100 Rising Stars in 2018 and 2019, as well as in their Corporate Venture Powerlist in 2022. Additionally, he is an advisor to the University of Michigan's Biomedical Venture Fund and on the External Advisory Committee for the Institute of Augmented Intelligence at Northwestern University's Feinberg School of Medicine.